TawandaGumboMD

Mycobacterial Disease

Director of Research Programs in Global Health & Associate Professor of Medicine

Dr. Gumbo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
UT Southwestern Medical Ctr
5323 Harry Hines BLVD
Dallas, TX 75390
Phone+1 214-648-9914

Fax+1 214-648-2741

Cleveland Clinic FoundationFellowship, Infectious Disease, 1996 - 1999
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1993 - 1996
University of Zimbabwe Huggins SOMClass of 1991

PubMed

8 citations
Omadacycline Pharmacokinetics/Pharmacodynamics in the Hollow Fiber System Model and Potential Combination Regimen for Short Course Treatment of Mycobacterium kansasii ...
Sanjay Singh, Tawanda Gumbo, Gunavanthi D Boorgula, Prem Shankar, Scott K Heysell
Antimicrobial Agents and Chemotherapy. 2022-09-20
12 citations
Once-a-week tigecycline for the treatment of drug-resistant TB.
Devyani Deshpande, Gesham Magombedze, Shashikant Srivastava, Paula Bendet, Pooi S Lee
The Journal of Antimicrobial Chemotherapy. 2019-06-01
10 citations
Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease.
Sanjay Singh, Jann-Yuan Wang, Scott K Heysell, Pamela J McShane, Carly Wadle
International Journal of Antimicrobial Agents. 2023-07-01

Journal Articles

Oxford University Press Has Registered This DOI Pre-Publication
Tawanda Gumbo, MD, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Tawanda Gumbo, Devyani Deshpande, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Devyani Deshpande, Tawanda Gumbo, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Devyani Deshpande, Tawanda Gumbo, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Scott K Heysell, Tawanda Gumbo, Eric R Houpt, Devyani Deshpande, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Devyani Deshpande, Scott K Heysell, Tawanda Gumbo, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Scott K Heysell, Devyani Deshpande, Tawanda Gumbo, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Tawanda Gumbo, Devyani Deshpande, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Tawanda Gumbo, Devyani Deshpande, Oxford University Press
Oxford University Press Has Registered This DOI Pre-Publication
Tawanda Gumbo, Devyani Deshpande, Oxford University Press
Join now to see all

Abstracts/Posters

Oxford University Press Has Registered This DOI Pre-Publication
Tawanda Gumbo, MD, Oxford University Press, Orlando, FL, 12/7/2019

Praedicare Inc. Receives Grant to Evaluate Potential New Drug Regimens for TuberculosisJune 17th, 2021
New Tool for an Old Disease: Use of PET and CT Scans May Help Develop Shorter TB TreatmentFebruary 24th, 2020
New Tool for an Old Disease: Use of PET and CT Scans May Help Develop Shorter TB TreatmentFebruary 24th, 2020
Join now to see all

PK-PD Of Combination Antituberculosis Therapy For Suppression Of Drug-ResistanceNational Institute Of Allergy And Infectious Diseases2008–2011
Efflux PUMP Inhibitors To Reduce Duration Of Antituberculosis TherapyOffice Of The Director, National Institutes Of Health2007